Transfusion adverse events in a tertiary hospital from 2016 to 2022: a retrospective analysis

Journal Title: Chinese Journal of Blood Transfusion - Year 2023, Vol 36, Issue 7

Abstract

Objective To strengthen the management of transfusion adverse events, so as to reduce the occurrence of medical damage and accidents, and guarantee the safety of blood transfusion. Methods The adverse events of blood transfusion reported in our hospital from July 2016 to December 2022 were collected, the reasons were tracked, and continuous improvements were made. Results From 2016 to 2022, a total of 315 transfusion adverse events were reported, including 233(73.97%, 233/315) cases of transfusion reactions and 82(26.03%, 82/315) transfusion adverse events. There were 271 328 transfusion cases in the same period, and the incidence of transfusion reactions was 0.858 7‰(233/271 328). The number of transfusion application was 129 887, and the incidence of transfusion adverse event is 0.631 3‰(82/129 887). Sixty-eigtht(82.93%, 68/82) cases of transfusion adverse events were caused by human factors, while the other 14(17.07%, 14/82) cases were non-human factors. According to the linear regression analysis, we have concluded that the year is a significant indicator for transfusion reaction rates (P<0.05), but not for transfusion adverse event rates (P>0.05). Conclusion Strengthening the management of reporting adverse events in clinical blood transfusion, monitoring the incidence, analyzing and improving different types of adverse events by management tools can reduce the medical risks of blood transfusion and help to guarantee the safety of clinical blood transfusion.

Authors and Affiliations

Yachun SUN, Leiping WANG, Guihua DENG, Xinyan LONG, Shunling YUAN, Qingbao MENG

Keywords

Related Articles

HBV genotyping and population genetics analysis of voluntary blood donors in five regions of China

Objective To investigate the distribution of Hepatitis B virus(HBV)genotypes and the genetic characteristics of genotype B HBV populations among voluntary blood donors in five regions of China. Methods A total number of...

Molecular genetics research of a Chinese family carrying triple HLA-A alleles

Objective To determine molecular basis of a rare HLA-A typing results carrying triple A alleles in potential allo-HSCT donor and her family. Methods HLA-A, -B, -C, -DRB1, -DQB1, -E, -F, -G of 5 members in the family were...

Investigation on the safety of regular plasma donors aged 56-60 years

Objective To investigate the safety of regular plasma donors aged 55 to 60, so as to provide reference for retention and recruitment of elderly plasma donors in China. Methods Plasma donors from 9 blood products manufact...

Analysis on blood donation of college student groups in Tianjin, 2012-2021

Objective To investigate the basic situation of blood donation given by university students in Tianjin and provide data to support the sustainable development of college blood donation. Methods The group blood donation i...

Abnormal blood transfusion compatibility test results caused by delayed hemolytic reaction: a case report and transfusion strategy

Objective To investigate the blood transfusion compatibility test results of a child with thalassemia after delayed hemolysis reaction, and to formulate transfusion strategies based on other clinical data to ensure the s...

Download PDF file
  • EP ID EP738590
  • DOI 10.13303/j.cjbt.issn.1004-549x.2023.07.011
  • Views 47
  • Downloads 0

How To Cite

Yachun SUN, Leiping WANG, Guihua DENG, Xinyan LONG, Shunling YUAN, Qingbao MENG (2023). Transfusion adverse events in a tertiary hospital from 2016 to 2022: a retrospective analysis. Chinese Journal of Blood Transfusion, 36(7), -. https://europub.co.uk/articles/-A-738590